INmune Bio Inc.
Symbol: NYSE: INMB
Market Cap: Private
- A novel strategy that treats Alzheimer’s disease as an immunologic, not neurologic disease.
- Our goal is to remodel, repair and restore the aging brain to prevent cognitive decline, not to slow cognitive decline.
- In Phase II clinical trials with top line data in 12 months